Request for Covid-19 Impact Assessment of this Report
The United States NSAIDs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global NSAIDs market, reaching US$ million by the year 2028. As for the Europe NSAIDs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main NSAIDs players cover Bayer, Novacap, Abbott, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of NSAIDs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Back Pain Treatment
Osteoarthritis Treatment
Other Disease Treatment
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bayer
Novacap
Abbott
Pfizer
Johnson & Johnson
Cigna
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
GlaxoSmithKline
Reddy Pharmaceuticals
Verywell
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global NSAIDs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for NSAIDs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for NSAIDs by Country/Region, 2017, 2022 & 2028
2.2 NSAIDs Segment by Type
2.2.1 Aspirin
2.2.2 Ibuprofen
2.2.3 Naproxen
2.2.4 Nabumetone
2.2.5 Others
2.3 NSAIDs Sales by Type
2.3.1 Global NSAIDs Sales Market Share by Type (2017-2022)
2.3.2 Global NSAIDs Revenue and Market Share by Type (2017-2022)
2.3.3 Global NSAIDs Sale Price by Type (2017-2022)
2.4 NSAIDs Segment by Application
2.4.1 Back Pain Treatment
2.4.2 Osteoarthritis Treatment
2.4.3 Other Disease Treatment
2.5 NSAIDs Sales by Application
2.5.1 Global NSAIDs Sale Market Share by Application (2017-2022)
2.5.2 Global NSAIDs Revenue and Market Share by Application (2017-2022)
2.5.3 Global NSAIDs Sale Price by Application (2017-2022)
3 Global NSAIDs by Company
3.1 Global NSAIDs Breakdown Data by Company
3.1.1 Global NSAIDs Annual Sales by Company (2020-2022)
3.1.2 Global NSAIDs Sales Market Share by Company (2020-2022)
3.2 Global NSAIDs Annual Revenue by Company (2020-2022)
3.2.1 Global NSAIDs Revenue by Company (2020-2022)
3.2.2 Global NSAIDs Revenue Market Share by Company (2020-2022)
3.3 Global NSAIDs Sale Price by Company
3.4 Key Manufacturers NSAIDs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers NSAIDs Product Location Distribution
3.4.2 Players NSAIDs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for NSAIDs by Geographic Region
4.1 World Historic NSAIDs Market Size by Geographic Region (2017-2022)
4.1.1 Global NSAIDs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global NSAIDs Annual Revenue by Geographic Region
4.2 World Historic NSAIDs Market Size by Country/Region (2017-2022)
4.2.1 Global NSAIDs Annual Sales by Country/Region (2017-2022)
4.2.2 Global NSAIDs Annual Revenue by Country/Region
4.3 Americas NSAIDs Sales Growth
4.4 APAC NSAIDs Sales Growth
4.5 Europe NSAIDs Sales Growth
4.6 Middle East & Africa NSAIDs Sales Growth
5 Americas
5.1 Americas NSAIDs Sales by Country
5.1.1 Americas NSAIDs Sales by Country (2017-2022)
5.1.2 Americas NSAIDs Revenue by Country (2017-2022)
5.2 Americas NSAIDs Sales by Type
5.3 Americas NSAIDs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NSAIDs Sales by Region
6.1.1 APAC NSAIDs Sales by Region (2017-2022)
6.1.2 APAC NSAIDs Revenue by Region (2017-2022)
6.2 APAC NSAIDs Sales by Type
6.3 APAC NSAIDs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe NSAIDs by Country
7.1.1 Europe NSAIDs Sales by Country (2017-2022)
7.1.2 Europe NSAIDs Revenue by Country (2017-2022)
7.2 Europe NSAIDs Sales by Type
7.3 Europe NSAIDs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa NSAIDs by Country
8.1.1 Middle East & Africa NSAIDs Sales by Country (2017-2022)
8.1.2 Middle East & Africa NSAIDs Revenue by Country (2017-2022)
8.2 Middle East & Africa NSAIDs Sales by Type
8.3 Middle East & Africa NSAIDs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of NSAIDs
10.3 Manufacturing Process Analysis of NSAIDs
10.4 Industry Chain Structure of NSAIDs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 NSAIDs Distributors
11.3 NSAIDs Customer
12 World Forecast Review for NSAIDs by Geographic Region
12.1 Global NSAIDs Market Size Forecast by Region
12.1.1 Global NSAIDs Forecast by Region (2023-2028)
12.1.2 Global NSAIDs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global NSAIDs Forecast by Type
12.7 Global NSAIDs Forecast by Application
13 Key Players Analysis
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer NSAIDs Product Offered
13.1.3 Bayer NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 Novacap
13.2.1 Novacap Company Information
13.2.2 Novacap NSAIDs Product Offered
13.2.3 Novacap NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Novacap Main Business Overview
13.2.5 Novacap Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott NSAIDs Product Offered
13.3.3 Abbott NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer NSAIDs Product Offered
13.4.3 Pfizer NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson NSAIDs Product Offered
13.5.3 Johnson & Johnson NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Cigna
13.6.1 Cigna Company Information
13.6.2 Cigna NSAIDs Product Offered
13.6.3 Cigna NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Cigna Main Business Overview
13.6.5 Cigna Latest Developments
13.7 Geri-Care Pharmaceuticals
13.7.1 Geri-Care Pharmaceuticals Company Information
13.7.2 Geri-Care Pharmaceuticals NSAIDs Product Offered
13.7.3 Geri-Care Pharmaceuticals NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Geri-Care Pharmaceuticals Main Business Overview
13.7.5 Geri-Care Pharmaceuticals Latest Developments
13.8 Perrigo Company
13.8.1 Perrigo Company Company Information
13.8.2 Perrigo Company NSAIDs Product Offered
13.8.3 Perrigo Company NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Perrigo Company Main Business Overview
13.8.5 Perrigo Company Latest Developments
13.9 Kopran
13.9.1 Kopran Company Information
13.9.2 Kopran NSAIDs Product Offered
13.9.3 Kopran NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Kopran Main Business Overview
13.9.5 Kopran Latest Developments
13.10 Merck Sharp & Dohme
13.10.1 Merck Sharp & Dohme Company Information
13.10.2 Merck Sharp & Dohme NSAIDs Product Offered
13.10.3 Merck Sharp & Dohme NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Merck Sharp & Dohme Main Business Overview
13.10.5 Merck Sharp & Dohme Latest Developments
13.11 Sun Pharmaceutical Industries
13.11.1 Sun Pharmaceutical Industries Company Information
13.11.2 Sun Pharmaceutical Industries NSAIDs Product Offered
13.11.3 Sun Pharmaceutical Industries NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Sun Pharmaceutical Industries Main Business Overview
13.11.5 Sun Pharmaceutical Industries Latest Developments
13.12 GlaxoSmithKline
13.12.1 GlaxoSmithKline Company Information
13.12.2 GlaxoSmithKline NSAIDs Product Offered
13.12.3 GlaxoSmithKline NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 GlaxoSmithKline Main Business Overview
13.12.5 GlaxoSmithKline Latest Developments
13.13 Reddy Pharmaceuticals
13.13.1 Reddy Pharmaceuticals Company Information
13.13.2 Reddy Pharmaceuticals NSAIDs Product Offered
13.13.3 Reddy Pharmaceuticals NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Reddy Pharmaceuticals Main Business Overview
13.13.5 Reddy Pharmaceuticals Latest Developments
13.14 Verywell
13.14.1 Verywell Company Information
13.14.2 Verywell NSAIDs Product Offered
13.14.3 Verywell NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Verywell Main Business Overview
13.14.5 Verywell Latest Developments
14 Research Findings and Conclusion
Table 1. NSAIDs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. NSAIDs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Aspirin
Table 4. Major Players of Ibuprofen
Table 5. Major Players of Naproxen
Table 6. Major Players of Nabumetone
Table 7. Major Players of Others
Table 8. Global NSAIDs Sales by Type (2017-2022) & (K Pcs)
Table 9. Global NSAIDs Sales Market Share by Type (2017-2022)
Table 10. Global NSAIDs Revenue by Type (2017-2022) & ($ million)
Table 11. Global NSAIDs Revenue Market Share by Type (2017-2022)
Table 12. Global NSAIDs Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global NSAIDs Sales by Application (2017-2022) & (K Pcs)
Table 14. Global NSAIDs Sales Market Share by Application (2017-2022)
Table 15. Global NSAIDs Revenue by Application (2017-2022)
Table 16. Global NSAIDs Revenue Market Share by Application (2017-2022)
Table 17. Global NSAIDs Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global NSAIDs Sales by Company (2020-2022) & (K Pcs)
Table 19. Global NSAIDs Sales Market Share by Company (2020-2022)
Table 20. Global NSAIDs Revenue by Company (2020-2022) ($ Millions)
Table 21. Global NSAIDs Revenue Market Share by Company (2020-2022)
Table 22. Global NSAIDs Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers NSAIDs Producing Area Distribution and Sales Area
Table 24. Players NSAIDs Products Offered
Table 25. NSAIDs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global NSAIDs Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global NSAIDs Sales Market Share Geographic Region (2017-2022)
Table 30. Global NSAIDs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global NSAIDs Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global NSAIDs Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global NSAIDs Sales Market Share by Country/Region (2017-2022)
Table 34. Global NSAIDs Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global NSAIDs Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas NSAIDs Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas NSAIDs Sales Market Share by Country (2017-2022)
Table 38. Americas NSAIDs Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas NSAIDs Revenue Market Share by Country (2017-2022)
Table 40. Americas NSAIDs Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas NSAIDs Sales Market Share by Type (2017-2022)
Table 42. Americas NSAIDs Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas NSAIDs Sales Market Share by Application (2017-2022)
Table 44. APAC NSAIDs Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC NSAIDs Sales Market Share by Region (2017-2022)
Table 46. APAC NSAIDs Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC NSAIDs Revenue Market Share by Region (2017-2022)
Table 48. APAC NSAIDs Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC NSAIDs Sales Market Share by Type (2017-2022)
Table 50. APAC NSAIDs Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC NSAIDs Sales Market Share by Application (2017-2022)
Table 52. Europe NSAIDs Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe NSAIDs Sales Market Share by Country (2017-2022)
Table 54. Europe NSAIDs Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe NSAIDs Revenue Market Share by Country (2017-2022)
Table 56. Europe NSAIDs Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe NSAIDs Sales Market Share by Type (2017-2022)
Table 58. Europe NSAIDs Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe NSAIDs Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa NSAIDs Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa NSAIDs Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa NSAIDs Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa NSAIDs Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa NSAIDs Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa NSAIDs Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa NSAIDs Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa NSAIDs Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of NSAIDs
Table 69. Key Market Challenges & Risks of NSAIDs
Table 70. Key Industry Trends of NSAIDs
Table 71. NSAIDs Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. NSAIDs Distributors List
Table 74. NSAIDs Customer List
Table 75. Global NSAIDs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global NSAIDs Sales Market Forecast by Region
Table 77. Global NSAIDs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global NSAIDs Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas NSAIDs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas NSAIDs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC NSAIDs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC NSAIDs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe NSAIDs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe NSAIDs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa NSAIDs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa NSAIDs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global NSAIDs Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global NSAIDs Sales Market Share Forecast by Type (2023-2028)
Table 89. Global NSAIDs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global NSAIDs Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global NSAIDs Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global NSAIDs Sales Market Share Forecast by Application (2023-2028)
Table 93. Global NSAIDs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global NSAIDs Revenue Market Share Forecast by Application (2023-2028)
Table 95. Bayer Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 96. Bayer NSAIDs Product Offered
Table 97. Bayer NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. Bayer Main Business
Table 99. Bayer Latest Developments
Table 100. Novacap Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 101. Novacap NSAIDs Product Offered
Table 102. Novacap NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Novacap Main Business
Table 104. Novacap Latest Developments
Table 105. Abbott Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 106. Abbott NSAIDs Product Offered
Table 107. Abbott NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Abbott Main Business
Table 109. Abbott Latest Developments
Table 110. Pfizer Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 111. Pfizer NSAIDs Product Offered
Table 112. Pfizer NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. Pfizer Main Business
Table 114. Pfizer Latest Developments
Table 115. Johnson & Johnson Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 116. Johnson & Johnson NSAIDs Product Offered
Table 117. Johnson & Johnson NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. Johnson & Johnson Main Business
Table 119. Johnson & Johnson Latest Developments
Table 120. Cigna Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 121. Cigna NSAIDs Product Offered
Table 122. Cigna NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. Cigna Main Business
Table 124. Cigna Latest Developments
Table 125. Geri-Care Pharmaceuticals Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 126. Geri-Care Pharmaceuticals NSAIDs Product Offered
Table 127. Geri-Care Pharmaceuticals NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 128. Geri-Care Pharmaceuticals Main Business
Table 129. Geri-Care Pharmaceuticals Latest Developments
Table 130. Perrigo Company Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 131. Perrigo Company NSAIDs Product Offered
Table 132. Perrigo Company NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 133. Perrigo Company Main Business
Table 134. Perrigo Company Latest Developments
Table 135. Kopran Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 136. Kopran NSAIDs Product Offered
Table 137. Kopran NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 138. Kopran Main Business
Table 139. Kopran Latest Developments
Table 140. Merck Sharp & Dohme Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 141. Merck Sharp & Dohme NSAIDs Product Offered
Table 142. Merck Sharp & Dohme NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 143. Merck Sharp & Dohme Main Business
Table 144. Merck Sharp & Dohme Latest Developments
Table 145. Sun Pharmaceutical Industries Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 146. Sun Pharmaceutical Industries NSAIDs Product Offered
Table 147. Sun Pharmaceutical Industries NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 148. Sun Pharmaceutical Industries Main Business
Table 149. Sun Pharmaceutical Industries Latest Developments
Table 150. GlaxoSmithKline Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 151. GlaxoSmithKline NSAIDs Product Offered
Table 152. GlaxoSmithKline NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 153. GlaxoSmithKline Main Business
Table 154. GlaxoSmithKline Latest Developments
Table 155. Reddy Pharmaceuticals Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 156. Reddy Pharmaceuticals NSAIDs Product Offered
Table 157. Reddy Pharmaceuticals NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 158. Reddy Pharmaceuticals Main Business
Table 159. Reddy Pharmaceuticals Latest Developments
Table 160. Verywell Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 161. Verywell NSAIDs Product Offered
Table 162. Verywell NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 163. Verywell Main Business
Table 164. Verywell Latest Developments
List of Figures
Figure 1. Picture of NSAIDs
Figure 2. NSAIDs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global NSAIDs Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global NSAIDs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. NSAIDs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Aspirin
Figure 10. Product Picture of Ibuprofen
Figure 11. Product Picture of Naproxen
Figure 12. Product Picture of Nabumetone
Figure 13. Product Picture of Others
Figure 14. Global NSAIDs Sales Market Share by Type in 2021
Figure 15. Global NSAIDs Revenue Market Share by Type (2017-2022)
Figure 16. NSAIDs Consumed in Back Pain Treatment
Figure 17. Global NSAIDs Market: Back Pain Treatment (2017-2022) & (K Pcs)
Figure 18. NSAIDs Consumed in Osteoarthritis Treatment
Figure 19. Global NSAIDs Market: Osteoarthritis Treatment (2017-2022) & (K Pcs)
Figure 20. NSAIDs Consumed in Other Disease Treatment
Figure 21. Global NSAIDs Market: Other Disease Treatment (2017-2022) & (K Pcs)
Figure 22. Global NSAIDs Sales Market Share by Application (2017-2022)
Figure 23. Global NSAIDs Revenue Market Share by Application in 2021
Figure 24. NSAIDs Revenue Market by Company in 2021 ($ Million)
Figure 25. Global NSAIDs Revenue Market Share by Company in 2021
Figure 26. Global NSAIDs Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global NSAIDs Revenue Market Share by Geographic Region in 2021
Figure 28. Global NSAIDs Sales Market Share by Region (2017-2022)
Figure 29. Global NSAIDs Revenue Market Share by Country/Region in 2021
Figure 30. Americas NSAIDs Sales 2017-2022 (K Pcs)
Figure 31. Americas NSAIDs Revenue 2017-2022 ($ Millions)
Figure 32. APAC NSAIDs Sales 2017-2022 (K Pcs)
Figure 33. APAC NSAIDs Revenue 2017-2022 ($ Millions)
Figure 34. Europe NSAIDs Sales 2017-2022 (K Pcs)
Figure 35. Europe NSAIDs Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa NSAIDs Sales 2017-2022 (K Pcs)
Figure 37. Middle East & Africa NSAIDs Revenue 2017-2022 ($ Millions)
Figure 38. Americas NSAIDs Sales Market Share by Country in 2021
Figure 39. Americas NSAIDs Revenue Market Share by Country in 2021
Figure 40. United States NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC NSAIDs Sales Market Share by Region in 2021
Figure 45. APAC NSAIDs Revenue Market Share by Regions in 2021
Figure 46. China NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 50. India NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe NSAIDs Sales Market Share by Country in 2021
Figure 53. Europe NSAIDs Revenue Market Share by Country in 2021
Figure 54. Germany NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 55. France NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa NSAIDs Sales Market Share by Country in 2021
Figure 60. Middle East & Africa NSAIDs Revenue Market Share by Country in 2021
Figure 61. Egypt NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of NSAIDs in 2021
Figure 67. Manufacturing Process Analysis of NSAIDs
Figure 68. Industry Chain Structure of NSAIDs
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...